Search

Author/Creator Atallah, Ehab L.

1. Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia. Issue 1 (2nd January 2021)

Authors:
Mushtaq, Muhammad Umair; Harrington, Alexandra M.; Chaudhary, Sibgha Gull; Michaelis, Laura C.; Carlson, Karen-Sue B.; Abedin, Sameem; Runass, Lyndsey; Callander, Natalie S.; Fallon, Michael J.; Juckett, Mark; Hall, Aric C.; Hematti, Peiman; Mattison, Ryan J.; Atallah, Ehab L.; Guru Murthy, Guru ...
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 1(2021)
Page Start:
158
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates. Issue 7 (7th June 2021)

Authors:
Atallah, Ehab L.; Sadek, Islam; Maegawa, Rodrigo; Cao, Xiting; Latremouille-Viau, Dominick; Pivneva, Irina; Rossi, Carmine; Guerin, Annie; Kota, Vamsi
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 7(2021)
Page Start:
1730
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Tyrosine kinase inhibitor therapy treatment and discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States: a clinical practice perspective. Issue 6 (12th May 2019)

Authors:
Ritchie, Ellen K.; Latremouille-Viau, Dominick; Guerin, Annie; Pivneva, Irina; Habucky, Karen; Ndife, Briana; Joseph, George J.; Atallah, Ehab L.
Journal:
Leukemia & lymphoma
Issue:
Volume 60:Issue 6(2019)
Page Start:
1476
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗